![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Breast Cancer |
Free Subscription
1 Am J Clin Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
High Dynamic Range Dual-Modal White Light Imaging Improves the Accuracy of Tumor
Bed Sampling After Neoadjuvant Therapy for Breast Cancer.
Am J Clin Pathol. 2023 Feb 17:aqac167. doi: 10.1093.
PubMed
Abstract available
Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and
Prostate Cancers.
Ann Surg Oncol. 2023;30:1312-1326.
PubMed
Abstract available
Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on
Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other
Local Recurrences.
Ann Surg Oncol. 2023;30:1678-1686.
PubMed
Abstract available
ASO Author Reflections: Is Nipple-Areolar Recurrence After Nipple-Sparing
Mastectomy Simply a "Cosmetic Failure"?
Ann Surg Oncol. 2023;30:1687-1688.
PubMed
ASO Visual Abstract: Genetic Testing Among Patients with High-Risk Breast,
Ovarian, Pancreatic, and Prostate Cancers.
Ann Surg Oncol. 2023;30:1329-1330.
PubMed
Patient-Reported Outcomes of Breast Reconstruction: Does the Quality of Decisions
Matter?
Ann Surg Oncol. 2023;30:1891-1900.
PubMed
Abstract available
Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian
Series.
Ann Surg Oncol. 2023;30:1700-1709.
PubMed
Abstract available
ASO Author Reflections: Surgical Management of Phyllodes Tumors of the Breast.
Ann Surg Oncol. 2023;30:1710-1711.
PubMed
Magnetic-Guided Occult Lesion Localization (M-GOLL): An Exploratory Feasibility
Study of Preoperative CT-Guided Puncture and Intraoperative Magnetic Seed
Localization for Minimally Invasive Surgical Resection of Non-palpable Pulmonary
Lesions.
Ann Surg Oncol. 2023;30:1309-1311.
PubMed
Surgeon Perspectives on Determinants of Same-Day Mastectomy: A Roadmap for
Implementing Change.
Ann Surg Oncol. 2023;30:1712-1720.
PubMed
Abstract available
ASO Visual Abstract: Patient-Reported Outcomes of Breast Reconstruction: Does the
Quality of Decisions Matter?
Ann Surg Oncol. 2023;30:1902-1903.
PubMed
ASO Author Reflections: Breast Reconstruction Decision Quality and
Patient-Reported Outcomes.
Ann Surg Oncol. 2023;30:1901.
PubMed
ASO Visual Abstract: Surgeon Perspectives on Determinants of Same-Day Mastectomy:
A Roadmap for Implementing Change.
Ann Surg Oncol. 2023;30:1721.
PubMed
ASO Visual Abstract: Survival After Breast-Conserving Surgery Compared with that
After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2023 Feb 15. doi: 10.1245/s10434-023-13154.
PubMed
Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in
hormone receptor negative breast cancer and evaluation of impact on overall
survival.
BMC Cancer. 2023;23:158.
PubMed
Abstract available
Colorectal cancer survivors' long-term recollections of their illness and therapy
up to seven years after enrolment into a randomised controlled clinical trial.
BMC Cancer. 2023;23:149.
PubMed
Abstract available
Efficacy of subsequent treatments in patients with hormone-positive advanced
breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
BMC Cancer. 2023;23:136.
PubMed
Abstract available
Tumour-educated platelets for breast cancer detection: biological and technical
insights.
Br J Cancer. 2023 Feb 10. doi: 10.1038/s41416-023-02174.
PubMed
Abstract available
Breast Cancer (Dove Med Press)
Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically
Node-Negative Breast Cancer [Response to Letter].
Breast Cancer (Dove Med Press). 2023;15:133-134.
PubMed
Optimized Radiomics Nomogram Based on Automated Breast Ultrasound System: A
Potential Tool for Preoperative Prediction of Metastatic Lymph Node Burden in
Breast Cancer.
Breast Cancer (Dove Med Press). 2023;15:121-132.
PubMed
Abstract available
Diagnostic accuracy of a three-protein signature in women with suspicious breast
lesions: a multicenter prospective trial.
Breast Cancer Res. 2023;25:20.
PubMed
Abstract available
METTL3 depletion contributes to tumour progression and drug resistance via N6
methyladenosine-dependent mechanism in HR+HER2-breast cancer.
Breast Cancer Res. 2023;25:19.
PubMed
Abstract available
Risks of second non-breast primaries following breast cancer in women: a
systematic review and meta-analysis.
Breast Cancer Res. 2023;25:18.
PubMed
Abstract available
Estrogen therapy after breast cancer diagnosis and breast cancer mortality risk.
Breast Cancer Res Treat. 2023 Feb 11. doi: 10.1007/s10549-023-06871.
PubMed
Abstract available
Comparison of goserelin and leuprorelin for ovarian protection during
chemotherapy in young patients with breast cancer.
Breast Cancer Res Treat. 2023 Feb 13. doi: 10.1007/s10549-023-06877.
PubMed
Abstract available
Neighborhood and racial influences on triple negative breast cancer: evidence
from Northeast Ohio.
Breast Cancer Res Treat. 2023 Feb 13. doi: 10.1007/s10549-023-06883.
PubMed
Abstract available
Effects of preoperative magnetic resonance image on survival rates and surgical
planning in breast cancer conservative surgery: randomized controlled trial
(BREAST-MRI trial).
Breast Cancer Res Treat. 2023 Feb 14. doi: 10.1007/s10549-023-06884.
PubMed
Abstract available
Overexpression of POU3F2 promotes radioresistance in triple-negative breast
cancer via Akt pathway activation.
Breast Cancer Res Treat. 2023 Feb 17. doi: 10.1007/s10549-023-06876.
PubMed
Abstract available
Changes in mammographic density and risk of breast cancer among a diverse cohort
of women undergoing mammography screening.
Breast Cancer Res Treat. 2023 Feb 17. doi: 10.1007/s10549-023-06879.
PubMed
Abstract available
Advances in breast cancer presented in San Antonio.
Cancer. 2023;129:817-818.
PubMed
Variation in second breast cancer risk after primary invasive cancer by time
since primary cancer diagnosis and estrogen receptor status.
Cancer. 2023 Feb 15. doi: 10.1002/cncr.34679.
PubMed
Abstract available
Cancer Epidemiol Biomarkers Prev
Application of novel breast biospecimen cell type adjustment identifies shared
DNA methylation alterations in breast tissue and milk with breast cancer risk
factors.
Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-0405.
PubMed
Abstract available
Changes in breast cancer risk and risk factor profiles among U.S.-born and
immigrant Asian American women residing in the San Francisco Bay Area.
Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1128.
PubMed
Abstract available
Cellular transformation promotes the incorporation of docosahexaenoic acid into
the endolysosome-specific lipid bis(monoacylglycerol)phosphate in breast cancer.
Cancer Lett. 2023;557:216090.
PubMed
Abstract available
Dysregulation of mitochondrial translation caused by CBFB deficiency cooperates
with mutant PIK3CA and is a vulnerability in breast cancer.
Cancer Res. 2023 Feb 14:CAN-22-2525. doi: 10.1158/0008-5472.CAN-22-2525.
PubMed
Abstract available
Circ_0108942 Regulates the Progression of Breast Cancer by Regulating the
MiR-1178-3p/TMED3 Axis.
Clin Breast Cancer. 2022 Dec 23:S1526-8209(22)00293.
PubMed
Abstract available
Is Taxane Rechallenge Time Dependent in Patients With Advanced Triple-Negative
Breast Cancer?
Clin Breast Cancer. 2023 Jan 25:S1526-8209(23)00020.
PubMed
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic
mastectomy.
Eur J Cancer. 2023;181:79-91.
PubMed
Abstract available
Clinical utility of axillary nodal markers in breast cancer.
Eur J Surg Oncol. 2023 Feb 1:S0748-7983(22)01365.
PubMed
Abstract available
Combined proliferation and apoptosis index provides better risk stratification in
breast cancer.
Histopathology. 2023 Feb 13. doi: 10.1111/his.14887.
PubMed
Abstract available
Identification of target proteins for breast cancer genetic risk loci and blood
risk biomarkers in a large study by integrating genomic and proteomic data.
Int J Cancer. 2023 Feb 13. doi: 10.1002/ijc.34472.
PubMed
Abstract available
Lactate secreted via MCT4 from bone‑colonizing breast cancer excites sensory
neurons via GPR81.
Int J Oncol. 2023;62:39.
PubMed
Abstract available
Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for
Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial
Breast Radiotherapy.
Int J Radiat Oncol Biol Phys. 2023 Feb 14:S0360-3016(22)03689.
PubMed
Abstract available
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and
breast cancer progression.
J Clin Invest. 2023 Feb 16:e162324. doi: 10.1172/JCI162324.
PubMed
Abstract available
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki
for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic
Breast Cancer.
J Clin Oncol. 2023 Feb 13:JCO2202447. doi: 10.1200/JCO.22.02447.
PubMed
Abstract available
Cognitive Problems in Older Breast Cancer Survivors.
J Clin Oncol. 2023 Feb 13:JCO2202282. doi: 10.1200/JCO.22.02282.
PubMed
Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects
of Estrogen Receptor-Beta in Breast Cancer.
J Natl Cancer Inst. 2023 Feb 16:djad023. doi: 10.1093.
PubMed
Medicaid expansion, chemotherapy delays, and racial disparities among women with
early-stage breast cancer.
J Natl Cancer Inst. 2023 Feb 16:djad033. doi: 10.1093.
PubMed
Abstract available
Historical Redlining and Breast Cancer Treatment and Survival among older Women
in the US.
J Natl Cancer Inst. 2023 Feb 16:djad034. doi: 10.1093.
PubMed
Abstract available
Examining a decade of racial disparity in partial mastectomy and oncoplastic
surgery.
J Surg Oncol. 2023;127:541-549.
PubMed
Abstract available
The impact of intraoperative cavity shaving on re-excision rates in
breast-conserving surgery.
J Surg Oncol. 2023;127:527-534.
PubMed
Abstract available
Incidence of radiation-associated sarcoma after breast-conserving surgery plus
radiation.
J Surg Oncol. 2023;127:535-540.
PubMed
Abstract available
Validation of the revised 8th AJCC breast cancer clinical prognostic staging
system: analysis of 5321 cases from a single institution.
Mod Pathol. 2021;34:291-299.
PubMed
Abstract available
Interobserver Variation in the Assessment of Immunohistochemistry Expression
Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low
Levels of HER2 Expression by Adjusting the Criteria? An International
Interobserver Study.
Mod Pathol. 2023;36:100009.
PubMed
Abstract available
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
Mod Pathol. 2023;36:100032.
PubMed
Abstract available
Lack of Standardization in the Diagnosis of Invasive Lobular Carcinoma of the
Breast.
Mod Pathol. 2023;36:100041.
PubMed
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary
Endocrine Resistance.
Mod Pathol. 2023;36:100100.
PubMed
Abstract available
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival
Outcomes From Real-World Data of a Large Nationwide Cohort.
Mod Pathol. 2023;36:100087.
PubMed
Abstract available
The Role of Artificial Intelligence in Accurate Interpretation of HER2
Immunohistochemical Scores 0 and 1+ in Breast Cancer.
Mod Pathol. 2023;36:100054.
PubMed
Abstract available
Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer.
N Engl J Med. 2023;388:585-594.
PubMed
Abstract available
Overcoming Resistance - Omission of Radiotherapy for Low-Risk Breast Cancer.
N Engl J Med. 2023;388:652-653.
PubMed
Immunotherapy in breast cancer: an overview of current strategies and
perspectives.
NPJ Breast Cancer. 2023;9:7.
PubMed
Abstract available
LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer
through activating the Wnt/beta‑catenin pathway.
Oncol Rep. 2023;49:60.
PubMed
Abstract available
Drivers of disparities in stage at diagnosis among women with breast cancer:
South African breast cancers and HIV outcomes cohort.
PLoS One. 2023;18:e0281916.
PubMed
Abstract available
Emotional, inflammatory, and genetic factors of resilience and vulnerability to
depression in patients with premenopausal breast cancer: A longitudinal study
protocol.
PLoS One. 2023;18:e0279344.
PubMed
Abstract available
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Proc Natl Acad Sci U S A. 2023;120:e2205247120.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by